.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, CTPharma’s mix tilted toward Pre-Roll at 35.70% share with a year-over-year decline of 76.74% and a month-over-month drop of 25.51%, while Vapor Pens held 32.24% share with declines of 84.89% YoY and 19.70% MoM. Flower accounted for 22.74% share with a 92.04% YoY decline and a 17.94% MoM decline, as Concentrates at 5.72% contracted 78.48% YoY but eased to an 8.47% MoM decline. Topical, though only 3.59% share, was the outlier with a 4.98% YoY decline but a 25.94% MoM increase, against a brand-level YoY sales drop of 85.39% and an 11.11% YoY decrease in average price to $32.80. The pattern suggests CTPharma is consolidating volume into Pre-Roll and Vapor Pens despite sharper YoY contraction there, while Topical’s sequential rebound introduces a small counterweight that could stabilize mix if sustained.
Positionally, anchoring the largest share in Pre-Roll while holding rank 4 in Connecticut for that category indicates relevance in a segment with steep declines of 76.74% YoY and 25.51% MoM, implying that price or assortment actions may be required to defend placement as Flower’s 92.04% YoY decline reduces basket-building potential. With Vapor Pens falling 84.89% YoY and 19.70% MoM, the brand’s two biggest segments are contracting faster than Concentrates’ 78.48% YoY and 8.47% MoM declines, while Topical’s 25.94% MoM uptick against a modest 4.98% YoY dip signals a niche where incremental share can be gained. The implication is a rebalancing opportunity: lean into Topical and relatively steadier Concentrates to buffer volatility in Pre-Roll and Vapor Pens, while using the 11.11% YoY price decrease to test elasticities where category declines are most acute.
Competitive Landscape
CTPharma ranks #4 in CT Pre-Roll in May 2026, down 3 positions from #1 year over year and slipping 2 spots from #2 in February 2026, while its peak at #1 in January 2026 underscores a reversal in momentum; meanwhile, Theraplant climbed from #2 to #1 with 81.6% YoY sales growth and Comffy advanced from #9 to #3 with 143.6% YoY sales growth, indicating CTPharma’s relative share is being redistributed to faster-rising peers, and the rank trajectory implies CTPharma must counter accelerating competitor gains to prevent further decline from a former #1 position.
Notable Products
E85 (3.5g) posted the steepest decline in May 2026 at -28.6% MoM while sliding to rank 4, contrasting with Gush Mintz (3.5g) rising 35.0% MoM into rank 2, a spread that signals volatility within CTPharma’s flower lineup. Blue Andeze Shorties Pre-Roll 5-Pack (2g) holds rank 1 despite no MoM read, and Jokerz THCA Infused Shorties Pre-Roll 5-Pack (2g) fell -20.1% MoM at rank 5, indicating pressure on infused pre-rolls even as non-infused pre-rolls stay present at the top. Four of the top ten are Pre-Roll SKUs while three are Flower, and the only Topical sits at rank 8 with $15,557 in May 2026 sales, implying a portfolio leaning on pre-roll share for traffic while flower outcomes drive the month’s variability.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
